These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7762964)

  • 1. A hemoglobin A1C immunoassay method not affected by carbamylated hemoglobin.
    Rose AM; Tongate C; Valdes R
    Ann Clin Lab Sci; 1995; 25(1):13-9. PubMed ID: 7762964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme immunoassay of hemoglobin A1c: analytical characteristics and clinical performance for patients with diabetes mellitus, with and without uremia.
    Engbaek F; Christensen SE; Jespersen B
    Clin Chem; 1989 Jan; 35(1):93-7. PubMed ID: 2463121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin Raleigh results in factitiously low hemoglobin A1c when evaluated via immunoassay analyzer.
    Jain N; Kesimer M; Hoyer JD; Calikoglu AS
    J Diabetes Complications; 2011; 25(1):14-8. PubMed ID: 19896869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin Raleigh as the cause of a falsely increased hemoglobin A1C in an automated ion-exchange HPLC method.
    Chen D; Crimmins DL; Hsu FF; Lindberg FP; Scott MG
    Clin Chem; 1998 Jun; 44(6 Pt 1):1296-301. PubMed ID: 9625056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Labile glycated haemoglobin and carbamylated haemoglobin are still critical points for HbA
    Desmons A; Jaisson S; Leroy N; Gillery P; Guillard E
    Biochem Med (Zagreb); 2017 Jun; 27(2):378-386. PubMed ID: 28694727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of Hb A1c in chronic renal failure. Contribution of new methodologies].
    Flory E; Marzullo C; Bourderont D; Genestier S; Marichal B; Parent X
    Ann Biol Clin (Paris); 1996; 54(5):211-4. PubMed ID: 8869361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamylated hemoglobin remains a critical issue in HbA1c measurements.
    Szymezak J; Lavalard E; Martin M; Leroy N; Gillery P
    Clin Chem Lab Med; 2009; 47(5):612-3. PubMed ID: 19397488
    [No Abstract]   [Full Text] [Related]  

  • 8. Carbamylated hemoglobin interference in glycohemoglobin assays.
    Weykamp CW; Miedema K; de Haan T; Doelman CJ
    Clin Chem; 1999 Mar; 45(3):438-40. PubMed ID: 10053058
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of hemoglobin (Hb) E and HbD traits on measurements of glycated Hb (HbA1c) by 23 methods.
    Little RR; Rohlfing CL; Hanson S; Connolly S; Higgins T; Weykamp CW; D'Costa M; Luzzi V; Owen WE; Roberts WL
    Clin Chem; 2008 Aug; 54(8):1277-82. PubMed ID: 18556332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbamylated hemoglobin in prerenal azotemia.
    Frazao JM; Barth RH; Berlyne GM
    Nephron; 1995; 71(2):153-5. PubMed ID: 8569946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference of the Hope Hemoglobin With Hemoglobin A1c Results.
    Chakraborty S; Chanda D; Gain M; Krishnan P
    Lab Med; 2015; 46(3):221-5. PubMed ID: 26199262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of carbamylated hemoglobin by high-performance liquid chromatography.
    Kwan JT; Carr EC; Bending MR; Barron JL
    Clin Chem; 1990 Apr; 36(4):607-10. PubMed ID: 2323040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoturbidimetric assay of glycated hemoglobin.
    Metus P; Ruzzante N; Bonvicini P; Meneghetti M; Zaninotto M; Plebani M
    J Clin Lab Anal; 1999; 13(1):5-8. PubMed ID: 10025731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylated or carbamylated hemoglobin in uremia?
    Tesio F; Cecchin E; De Marchi S; Quaia P
    N Engl J Med; 1982 Apr; 306(17):1053-4. PubMed ID: 7063001
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of sickle cell trait and hemoglobin C trait on determinations of HbA1c by an immunoassay method.
    Roberts WL; McCraw M; Cook CB
    Diabetes Care; 1998 Jun; 21(6):983-6. PubMed ID: 9614618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the Afinion HbA1c Point-of-Care instrument be an alternative method for the Tosoh G8 in the case of Hb-Tacoma?
    Lenters-Westra E; Strunk A; Campbell P; Slingerland RJ
    Scand J Clin Lab Invest; 2017 Feb; 77(1):2-7. PubMed ID: 27191339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of total and A1c-glycosylated hemoglobin in human whole blood using sandwich immunoassays on polydimethylsiloxane-based antibody microarrays.
    Chen HH; Wu CH; Tsai ML; Huang YJ; Chen SH
    Anal Chem; 2012 Oct; 84(20):8635-41. PubMed ID: 22967096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple chemiluminescence immunoassay detection of the concentration ratio of glycosylated hemoglobin A1c to total hemoglobin in whole blood samples.
    Zhao H; Qiu X; Su E; Huang L; Zai Y; Liu Y; Chen H; Wang Z; Chen Z; Li S; Jin L; Deng Y; He N
    Anal Chim Acta; 2022 Feb; 1192():339379. PubMed ID: 35057955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of in vivo hemoglobin carbamylation on HbA1c measurements by various methods.
    Chachou A; Randoux C; Millart H; Chanard J; Gillery P
    Clin Chem Lab Med; 2000 Apr; 38(4):321-6. PubMed ID: 10928652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference of carbamylated and acetylated hemoglobins in assays of glycohemoglobin by HPLC, electrophoresis, affinity chromatography, and enzyme immunoassay.
    Weykamp CW; Penders TJ; Siebelder CW; Muskiet FA; van der Slik W
    Clin Chem; 1993 Jan; 39(1):138-42. PubMed ID: 8419039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.